Skip to content
  • Home
  • About Us
    • Our Science
    • Platform Technology
    • Intellectual PropertyIntellectual Property
    • Our Pipeline
    • Scientific Advisory BoardOur Scientific Advisory board
    • Our Partners
  • NewsNews and Press Releases
    • PublicationsNews and Press Releases
    • News/Press Releases
    • Events & Presentations
  • Contact UsContact Us Page
  • Data Page 1

    March 13, 2024

    •

    hoflanpe

    On this page, find downloadable, linked materials to the restricted page PDF Link to Download

NanoValent Pharmaceuticals

NanoValent Pharmaceuticals, Inc. is an early stage oncology drug discovery and development company. Its proprietary platform technology comprises novel format conjugate nano-ADC like Targeted NanoSpheres (nADC/TNS).

  • X
  • LinkedIn

About

  • HomeNanoValent Pharmaceuticals – Homepage
  • About UsNanoValent Pharmaceuticals – About Us
  • Our ScienceNanoValent Pharmaceuticals – Our Science
  • Platform TechnologyOur Platform Technology
  • Our PipelineNanovalent Pharmaceuticals – Our Pipeline
  • Investors
  • Accessibility Statement

Resources

  • Scientific Advisory BoardOur Scientific Advisory Board
  • PublicationsNanoValent Pharmaceuticals – Publications
  • News/Press Releases
  • CareersCareers
  • Privacy NoticePrivacy Notice
  • Terms & Conditions
  • FCOI Policy

Search

Looking for something specific? Try a search below!

Copyright © 2025 – 2026 | NanoValent Pharmaceuticals, Inc | All rights reserved | This website is designed by Sunvalley Communication, LLC